Clinical Trial Update: Role of Estrogen on Skeletal Outcomes in FHA [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by the University of Virginia is investigating how estrogen affects skeletal outcomes in functional hypothalamic amenorrhea, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Hypothalamic Amenorrhea
• Osteoporosis

Drugs mentioned

• Estrogen (Estrogen)

Snippet

Sponsor: University of Virginia | Conditions: Bone Strength, Bone Density | Phase 2 | Status: RECRUITING